Metraipolis › archive › dc_49d1ab0507ab

A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in… — Europe PMC PMID:41208546

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41208546
DOI
10.1093/cid/ciaf604
License (as archived)
solo-consultazione
Archived
2026-11-06T08:21:34.824Z
SHA-256 of the archived text
5cf43454ed309e7a8e3cd16ea1040e64c6e420d0b3464c78b7fc169f20bb3efb
Stable URL of this page
https://metraipolis.com/documento/dc_49d1ab0507ab

How to cite

A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in… — Europe PMC PMID:41208546 — Europe PMC (en), https://europepmc.org/article/MED/41208546 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_49d1ab0507ab (Metraipolis archive dc_49d1ab0507ab, sha256 5cf43454ed309e7a8e3cd16ea1040e64c6e420d0b3464c78b7fc169f20bb3efb)
BibTeX
@misc{dc49d1ab0507ab,
  title = {A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in… — Europe PMC PMID:41208546},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41208546},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_49d1ab0507ab; sha256 5cf43454ed309e7a8e3cd16ea1040e64c6e420d0b3464c78b7fc169f20bb3efb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41208546. Agents can read the archived copy with the MCP tool read_document.